Low-Cost Solutions to Maternal Mortality Already Exist

In early June, Melinda French Gates pledged $215 million to improve women’s health globally. This funding focuses on underfunded areas, such as maternal care in Africa. The announcement comes at a critical moment in global health. Every day, more than 700 women die during and following pregnancy and childbirth. This tragedy occurs despite the fact that many of the leading causes of maternal mortality are preventable. Affordable, evidence-based interventions exist to save these lives.

These maternal deaths are not distributed evenly across the globe. Roughly 87% of them occur in Southern Asia and Sub-Saharan Africa. Sub-Saharan Africa alone accounts for nearly 70% of these deaths. By contrast, high-income countries experience far lower rates. However, stark inequities remain even in wealthy nations. In the United States, for example, Black women are more than three times as likely as white women to die from maternity-related causes. This disparity highlights that access to care and quality of treatment vary significantly, regardless of a country’s overall wealth.

Declining foreign aid has exacerbated the crisis in lower-income countries. As calls for local resource mobilization grow louder, the focus must shift to cost-effectiveness. Policymakers can no longer rely solely on external funding to sustain maternal health programs. Instead, they must make better use of scarce resources. This means investing in simple, proven, and affordable interventions for the leading causes of maternal death. These causes include postpartum hemorrhage, hypertensive disorders such as pre-eclampsia, unsafe abortion complications, obstructed labor, and sepsis.

For too long, investment has favored expensive hospital-centered models. These models often fail to reach women in remote or resource-constrained settings. The challenge is no longer identifying solutions. The solutions already exist. The challenge is ensuring that proven interventions reach every woman in need. This requires a strategic shift in how health systems are funded and structured.